Explore

Capbase

Intelligent Therapeutics, Inc. — Funding, Investors & Profile — Capbase

Private

Private securities offering disclosed via SEC Form D.

Other Technology

$100KSource: [SEC]Total raised

UndisclosedSource: [SEC]Last valuation

Intelligent Therapeutics, Inc. filed a Form D notice of exempt offering with the SEC.

1 rounds

No investors recorded yet for Intelligent Therapeutics, Inc..

Leadership

Nathan BernsteinExecutive Officer · Chief Technology OfficerSince 2026Source: [SEC]

Thomas EmmonsExecutive Officer · Chief Financial Officer, SecretarySince 2026Source: [SEC]

Showing 2 of 5 — any approved contribution unlocks every profile for 30 days.Sign in to unlock

Intelligent Therapeutics, Inc. has no recorded acquisitions.

Still private — no exit on record.

No diversity signals recorded yet for Intelligent Therapeutics, Inc..

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.